University of Minnesota. Driven to Discover.
Though coverage still isn't optimal, for the first time rates topped 60%, with the boys' level gaining ground on the girls'.
ACIP spent several months reviewing clinical trial data that showed two doses in younger adolescents prompted an immune response similar to or higher than in young adults.
HPV vaccine uptake, though up slightly, was just 60% in girls and 42% in boys.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.